Acne aggravated and Impetigo

Summary:

Impetigo is found among people with Acne aggravated, especially for people who are male, 10-19 old.

The study analyzes which people have Impetigo with Acne aggravated. It is created by eHealthMe based on reports of 30 people who have Acne aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acne aggravated?

Acne aggravated (acne - a skin disease) is found to be associated with 1,241 drugs and 533 conditions by eHealthMe. Check the latest studies of Acne aggravated.

What is Impetigo?

Impetigo (contagious skin infection) is found to be associated with 332 drugs and 453 conditions by eHealthMe. Check the latest studies of Impetigo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

30 people who have Acne Aggravated and Impetigo are studied.

Would you have Impetigo when you have Acne aggravated?

Gender of people who have Acne Aggravated and experienced Impetigo *:

  • female: 44.83 %
  • male: 55.17 %

Age of people who have Acne Aggravated and experienced Impetigo *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 64 %
  • 20-29: 28 %
  • 30-39: 4 %
  • 40-49: 0.0 %
  • 50-59: 4 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Pharyngitis (inflammation of the pharynx, causing a sore throat): 2 people, 6.67%
  2. Sinusitis (inflammation of sinus): 1 person, 3.33%
  3. Rosacea (a skin condition that causes facial redness): 1 person, 3.33%
  4. Diarrhea: 1 person, 3.33%
  5. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 3.33%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.33%
  7. Acne Cystic (skin problems that cause pimples): 1 person, 3.33%

Common drugs taken by these people *:

  1. Accutane: 14 people, 46.67%
  2. Amnesteem: 8 people, 26.67%
  3. E-Mycin: 6 people, 20.00%
  4. Minocin: 6 people, 20.00%
  5. Aldactone: 6 people, 20.00%
  6. Sotret: 6 people, 20.00%
  7. Retin-A: 6 people, 20.00%
  8. Cleocin T: 5 people, 16.67%
  9. Myorisan: 3 people, 10.00%
  10. Multivitamin: 2 people, 6.67%

Common symptoms for these people *:

  1. Inflammatory Bowel Disease: 12 people, 40.00%
  2. Dry Skin: 11 people, 36.67%
  3. Rashes (redness): 11 people, 36.67%
  4. Intestinal Obstruction: 9 people, 30.00%
  5. Depression: 9 people, 30.00%
  6. Oral Herpes (viral infection of mouth): 8 people, 26.67%
  7. Cheilitis (infection of lips): 7 people, 23.33%
  8. Xerosis (abnormal dryness of the skin or mucus membranes): 6 people, 20.00%
  9. Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 6 people, 20.00%
  10. High Blood Cholesterol: 6 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Impetigo?

- Check whether Impetigo is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Impetigo:

All the conditions that are associated with Impetigo:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Impetigo and Acne aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: